Fossil Group (FOSL) Stock Closed Down on Competitor's Warning

NEW YORK (TheStreet) -- Fossil Group  (FOSL) stock closed down 6.55% to $28.66 today after the Swatch Group (SWGAY) CEO criticized the U.S. watch market. 

Swatch CEO Nick Hayek said the U.S. faces a weak market due to sluggish local consumption, the Fly reports. 

The Swiss watchmaker recently reported preliminary results for the first half of 2016, including a 12% sales decline and 50% drop in earnings. The shortfall could possibly be attributed to lower sales in Hong Kong and parts of Europe, Hayek noted. 

Hayek also predicts that the tragic attacks in Nice on Thursday will further weigh on sales estimates, Bloomberg reports. Swatch is slated to report its first-half earnings by July 21. 

Richemont (CFR) is also anticipating a weak first half. Shares of the luxury watchmaker closed down 3.08% to $58.15 on Friday. 

Swatch stock closed down 7.77% to $13.59 Friday afternoon. 

Separately, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author. TheStreet Ratings has this to say about the recommendation:

We rate FOSSIL GROUP INC as a Sell with a ratings score of D+. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself.

You can view the full analysis from the report here: FOSL

FOSL Chart FOSL data by YCharts

More from Markets

Market of the Week: E-mini S&P 500

Market of the Week: E-mini S&P 500

Bristol-Myers Slides After FDA Delays Marketing Approval for Cancer Therapy

Bristol-Myers Slides After FDA Delays Marketing Approval for Cancer Therapy

Dow Trades Lower After Momentum From China Rally Fades, Nasdaq Rises

Dow Trades Lower After Momentum From China Rally Fades, Nasdaq Rises

Goldman Women Find Bias in Pay as Corporate Old-Boy Clubs Endure

Goldman Women Find Bias in Pay as Corporate Old-Boy Clubs Endure

Can OPEC Still Influence the Price of Crude Oil?

Can OPEC Still Influence the Price of Crude Oil?